Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WallSt.net was a digital financial media and investor relations platform operated by Wall Street Network, Inc. During its peak in the mid-2000s, the company served as a prominent multimedia portal for micro-cap and small-cap companies, with a significant volume of its coverage dedicated to the biotechnology and healthcare sectors. The platform specialized in disseminating corporate news through executive audio and video interviews, research reports, and press release distribution. While it provided substantial visibility for emerging life science firms to reach retail investors, WallSt.net was a media entity rather than a drug developer or clinical research organization. The platform is currently inactive as a primary source for financial news.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WallSt.net.